Short-Term Debt to Capital: Revvity Inc (RVTY)

Brandmark of Revvity, Inc. (RVTY)

The short-term debt-to-equity structure dynamics for Revvity, Inc. (RVTY) on GURU.Markets include the 0.03 indicator, established as the baseline value. Jangi Nazaryan's team has successfully pivoted the company toward profitable diagnostics segments. Rising share prices are driving the divestment of non-core assets and a recovery in demand from the biotechnology sector. Business resilience is underpinned by recurring consumable sales and the R&D investment volumes of pharmaceutical behemoths.

RVTY - PerkinElmer Short-Term Debt to Capital over the range 02/21/2024 - 10/29/2026

Analytical breakdowns for Revvity, Inc.

- stock quotes and analyst forecast:
Stock Price PerkinElmer|RVTY - Average Forecast Price
- company stock exchange capitalization indicators:
Market Capitalization Revvity Inc|RVTY - Business Value
- book capitalization information:
Book Value per Share Revvity|RVTY - Book Capitalization|Market Value to Book Value Ratio revvity.com|RVTY - Total Business Assets
- business debt structure and liquidity details:
Total Debt to Capital Revvity, Inc.|RVTY - Long-Term Debt to Capital|Short-Term Debt to Equity Revvity|RVTY - Company Debts|Debt to Book Value Revvity Inc|RVTY - Long-Term Debt|Company Short-Term Debt Revvity|Quick Ratio revvity.com
- earnings and market ratios statistics:
RVTY - Net Financial Result
General company analysis:PerkinElmer RVTY
Brand item of Revvity

For Revvity, Inc., a provider of high-tech genomics and diagnostics solutions, the share of short-term loans in the company's equity reflects the degree of reliance on operational borrowing. This metric compares liabilities with a maturity of up to one year against total equity. Such a calculation reveals the balance sheet's vulnerability to sudden rate hikes or a credit crunch. A consistently low level of this indicator confirms financial stability and investment security.

Competitors of Revvity, Inc. (RVTY)

Short-Term Debt to Capital A|DGX - Current Liabilities to Capital|Short-Term Debt to Capital ILMN (Illumina, Inc.)|EXAS: Short-Term Debt to Capital Ratio|Bio-Rad - Short-Term Debt to Capital|NNNN - Short-Term Debt to Capital|Sterigenics (SHC) - Short-Term Debt to Equity|Short-Term Debt to Capital Ratio QDEL|OPK (OPKO Health, Inc.) - Short-Term Debt to Capital|Short-Term Debt to Capital CareDx Corp|Short-Term Debt to Equity Maravai LifeSciences Holdings, Inc. (MRVI)|Short-Term Debt to Equity FLGT (Fulgent Genetics Inc)|Fluidigm - Short-Term Debt to Equity Ratio|Cytek Corp (CTKB) - Current Liabilities to Capital|OSUR - Short-Term Debt to Equity|Short-Term Debt to Capital Coefficient Exagen Inc. XGN|MDXH: Short-Term Debt to Capital|LUCD - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Prenetics Global Limited|Insight Molecular (IMDX) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Trinity Biotech plc (TRIB)|PRPH (prophaselabs.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital AIMD (Ainos)|Co-Diagnostics Inc (CODX) - Current Liabilities to Capital|HSCS: Short-Term Debt to Equity Ratio|BMRA: Short-Term Debt to Equity|CDIO (cardiodiagnosticsinc.com) - Short-Term Debt to Equity Ratio|VRAX (viraxbiolabs.com) - Short-Term Debt to Equity|BJDX (Bluejay Diagnostics, Inc.) - Short-Term Debt to Capital|Aspira Women's Health, Inc. (AWH) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio AXDX (Accelerate Diagnostics, Inc)|Short-Term Loans to Capital Ratio CNTG|Enzo Biochem - Short-Term Debt to Equity Ratio|Fresh2 Group Ltd (FRES) - Current Liabilities to Capital|GENE: Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital ME (23andMe Holding Co)|PMD: Short-Term Debt to Capital